Pharmacy Preceptor

Rotation Precepted

  • PGY1 Ambulatory Oncology
  • PGY2 Grace Clinic Rotation (ambulatory hematopoietic cell transplant, malignant hematology, and cellular therapies)

Pharmacy School

Temple University, 2010

Residency Training Programs

  • PGY1 Pharmacy Residency at Penn State Hershey Medical Center, 2011
  • PGY2 Oncology Pharmacy Residency at Froedtert Hospital, 2012

Professional Interests

Malignant hematology, hematopoietic cell transplant, immunotherapy/cellular therapy, precepting/teaching

Organizational Involvement

  • Oncology P&T Subcommittee
  • Medical College of Wisconsin BMT QI Committee

Awards and Certifications

  • Board Certified Oncology Pharmacist (BCOP)
  • Advanced Cardiovascular Life Support (ACLS)

Publications

  • Canadeo A, Fournogerakis M, Zook F. A multi-disciplinary approach to managing chronic myelogenous leukemia patients on oral anticancer therapy at a large academic medical center. Curr Hematol Malig Rep. 2021; 6: 509-16.
  • George G, Rezazadeh A, Zook F et al. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase-A real world study. Leukemia Research. 2020; 94: 106368.
  • Rezazadeh A, George G, Pearl N, McCoy C, Zook F et al. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with asparaginase based regimens. Blood. 2018; 132: 1232.
  • Jerkins J, Hamadani M, Zook F et al. Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease. J Clin Hematol. 2017; 92(10): E610-1.
  • Weil EM, Zook F, Oxencis C et al. Evaluation of the pharmacokinetics and efficacy of a busulfan test dose in adult patients undergoing myeloablative hematopoietic cell transplant. Biol Blood and Marrow Transplantation. 2017; 23: 952-7.
  • Fajardo S, Zook F, Dotson E. Specialty pharmacy for hematologic malignancies. Am J Health-Syst Pharm. 2016; 73: e312-24.
  • Cotter J, Waggoner M, Larh S, Kluck S, Loyda J, Zook F. Moving out: transitioning an inpatient chemotherapy regimen to the outpatient setting. Oncology Nursing Forum. 2016; 43(2).
  • Barbor M, Zook F. Developing a pharmacist-driven drug-monitoring protocol. The Oncology Pharmacist. 2015;8(3): published online.
  • Dhakal B, D'Souza A, Arce-Lara C, Pasquini M, Saber W, Falvo F et al. Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis. Bone Marrow Transplant. 2015;50(4):610-2.
  • Schneidewend R, Carlson KB, Atallah E, Michaelis LC, Hosking PR, Hari P, Hamadani M, D’Souza A, Fenske TS, Pasquini MC, Chitambar CR, Raj RV, Johnston K, Essenmacher E, Zook F. Impact of immunophenotype and cytogenetics in early assessment of post induction response in acute myeloid leukemia (AML). Blood. 2015;126(23):4954.

Hobbies

I’ve played the piano since I was 5 years old, and still enjoy playing in my free time. I also love baking, especially cupcakes.

What is your favorite part of Milwaukee?

I really like going to new restaurants or breweries and finding new farmer’s markets. The summertime festivals along the lakefront are also really fun!

What is your favorite medication/trial/medical resource?

My favorite drug is brentuximab, since it was the first antibody-drug conjugate that wasn’t pulled from the market.